|
Author: Marie Guhmann, Markus Thommes, Frédéric Gerber, Norbert Pöllinger, Sandra Klein, Jörg Breitkreutz, Werner Weitschies
Keywords: biorelevant test setups,diclofenac,mouth exposure,multiple absorption peaks,orodispersible tablets
Summary: these models, diclofenac free acid and its sodium/potassium salt were comparatively evaluated for d To date, most of the marketed oral dosage forms of diclofenac comprise its sodium or potassium salt. of most common diclofenac sodium delayed-release (DR) preparations in fasted subjects is usually ch
Pharmaceutical Research; Vol. 30 Number 6, Jun 2013;Published Date:05/31/2013; DOI: 10.1007/s11095-013-0974-y
|
|
Author: Meltem Cetin, Alptug Atila, Yucel Kadioglu
Keywords: diclofenac sodium,Eudragit® L100,nanoparticles,PLGA,polymer blend
Summary: L100-PLGA Nanoparticles Containing Diclofenac Sodium
poly(lactic-co-glycolic acid) (PLGA) nanoparticles containing diclofenac sodium. effect in which diclofenac sodium release ranged
AAPS PharmSciTech; Vol. 11 Number 3, Sep 2010;Published Date:08/31/2010; DOI: 10.1208/s12249-010-9489-6
|
|
Author: Rouhollah Heydari, Mojtaba Shamsipur, Nasim Naleini
Keywords: diclofenac sodium,EDTA,high-performance liquid chromatography,pharmaceutical preparations,sorbic acid
Summary: sorbic acid, and diclofenac sodium was developed and validated. Diclofenac sodium [sodium (o-{(2,6-dichlorophenyl) amino}phenyl)acetate] is a synthetic nonsteroidal 0.1% w/v of diclofenac sodium, 0.1% w/v of disodium EDTA, and 0.2% w/v of sorbic acid) was obtained
AAPS PharmSciTech; Vol. 14 Number 2, Jun 2013;Published Date:05/31/2013; DOI: 10.1208/s12249-013-9962-0
|
|
Author: Golam Kibria, Monzurul Amin Roni, Mohammad Shahriarul Absar, Reza-ul Jalil
Keywords: aqueous coating,diclofenac sodium,Eudragit RS 30 D,plasticizer,thermal analysis
Summary: Effect of Plasticizer on Release Kinetics of Diclofenac Sodium Pellets Coated
TEC) and polyethylene glycol 6000 (PEG 6000) on the in vitro release kinetics of diclofenac sodium
aqueous coating; diclofenac sodium; Eudragit RS 30 D; plasticizer; thermal analysis.
AAPS PharmSciTech; Vol. 9 Number 4, Dec 2008;Published Date:11/30/2008; DOI: 10.1208/s12249-008-9163-4
|
|
Author: Bashar M. Al-Taani, Bassam M. Tashtoush
Keywords: controlled release,buffered matrix,swelling,erosion,sustained release
Summary: ces on the Release Characteristics of Diclofenac Sodium tern of diclofenac sodium. The release of diclofenac sodium
AAPS PharmSciTech; Vol. 4 Number 3, Sep 2003;Published Date:08/31/2003; DOI: 10.1208/pt040343
|
|
Author: Meena Rani, Brahmeshwar Mishra
Keywords: Matrix tablets,osmotic matrix tablets,osmotic pump tablets,controlled release,diclofenac sodium
Summary: ery of diclofenac sodium (DS) Diclofenac sodium (DS) is a substituted phenyl-acetic acid
Preparation of Osmotic Pump Tablets of Diclofenac Sodium
AAPS PharmSciTech; Vol. 5 Number 4, Dec 2004;Published Date:11/30/2004; DOI: 10.1208/pt050471
|
|
Author: Munish Ahuja, Avinash S. Dhake, Surendra K. Sharma, Dipak K. Majumdar
Keywords: anti-inflammatory,cyclodextrins,formulation,NSAID,ocular,PGE2
Summary: Aqueous ophthalmic solutions of NSAIDs have been made using sodium, potassium,
The AAPS Journal; Vol. 10 Number 2, Jun 2008;Published Date:05/31/2008; DOI: 10.1208/s12248-008-9024-9
|
|
Author: Biswajit Mukherjee, Subas Chandra Dinda, Bhakti Bhusan Barik
Keywords: enteric resistant,gum cordia,sustained-release tablet
Summary: Diclofenac sodium was procured from Macleods Phar- release marketed formulation of diclofenac sodium (Voveran
Table I. Composition of 100 mg Diclofenac Sodium Matrix Tablet
AAPS PharmSciTech; Vol. 9 Number 1, Mar 2008;Published Date:02/29/2008; DOI: 10.1208/s12249-008-9051-y
|